Q: Why did LLY book $71.5M of 1Q07 Byetta revenue, rather than the $66.9M figure mentioned above? With no knowledge of this deal I would gues in order: 1) Milestone payments being earned. 2) Byetta drugs used internally by ALMN (trials). Alternatively, is the ALMN deal exclusive (or does somebody else have rights somewhare in the world).